Drug regulations - Medical Facts

Bill in Congress to Eliminate Small vs Large Molecule Drug Distinctions

Medical Facts - February 25, 2025

In a recent development in Congress, lawmakers have put forth a bill aimed at amending a crucial aspect of the Inflation Reduction Act due...

BREAKING NEWS

Pfizer CEO Bourla’s Awkward Washington Encounter

Medical Facts - February 21, 2025

Pfizer CEO Bourla's Awkward Washington EncounterBluebird Bio, a biotech company, recently made headlines by avoiding bankruptcy through a strategic sale to investment firms Carlyle...

deadly-llness-in-congo-journalists-discuss-early-rfk-actions

Deadly Illness in Congo: Journalists Discuss Early RFK Actions

March 1, 2025

chaos-at-hhs-mpact-on-healthcare-kff-health-update

Chaos at HHS: Impact on Healthcare – KFF Health Update

January 24, 2025

Reforming the WHO: A Better Approach for the U.S.

January 18, 2025

Eli Lilly Joins Lawsuit on Compounded Drugs

January 6, 2025

jay-bhattacharya-evaluating-the-controversial-nh-candidate

Jay Bhattacharya: Evaluating the Controversial NIH Candidate

March 4, 2025

The Decline of Bone Marrow Transplants: Reasons and Trends

December 25, 2024

Winning Health Policy Valentines: A Dose of Love – KFF News

February 15, 2025

california-seeks-penalties-for-nsurers-that-deny-and-delay

California Seeks Penalties for Insurers That Deny and Delay

February 19, 2025

Scientists Express Concerns About Future of Research Under Trump Administration

February 17, 2025

Tag: Drug regulations

Bill in Congress to Eliminate Small vs Large Molecule Drug Distinctions

BREAKING NEWS

Pfizer CEO Bourla’s Awkward Washington Encounter

Deadly Illness in Congo: Journalists Discuss Early RFK Actions

Chaos at HHS: Impact on Healthcare – KFF Health Update

Reforming the WHO: A Better Approach for the U.S.

Eli Lilly Joins Lawsuit on Compounded Drugs

Jay Bhattacharya: Evaluating the Controversial NIH Candidate

The Decline of Bone Marrow Transplants: Reasons and Trends

Winning Health Policy Valentines: A Dose of Love – KFF News

California Seeks Penalties for Insurers That Deny and Delay

Scientists Express Concerns About Future of Research Under Trump Administration

Top News

Axsome submits Alzheimer’s disease drug for FDA approval after Phase 3 trials

Using Humor to Shed Light on the Darkness in Medicine: Dr. Glaucomflecken’s Approach

Navigating Aging as LGBTQ+ Individuals: Addressing Past Traumas – KFF Health News

Optimizing Online Marketing Strategies for GLP-1 Compounded Drugs: Balancing Benefits and Risks

Challenges in School Shooting Prevention Teams – KFF Health News